Cell-free DNA (cfDNA) has become a cornerstone of liquid biopsy, providing new opportunities for non-invasive diagnostics, disease monitoring, and personalized medicine. As technologies advance, the ability to decode circulating nucleic acids with precision is increasing – but so are the challenges of ensuring reliability, sensitivity, and standardized workflows.
In the expert session “Advanced liquid biopsy: From molecular insights to clinical implementation”, experts will examine the latest breakthroughs in cfDNA analysis, from cutting-edge molecular methods to robust pre-analytical practices that protect sample integrity. We aim to discuss the translation of these technologies into real-world diagnostic applications and explore the critical roles of workflow harmonization, quality assurance, and reproducibility.
We are delighted that Dr. Uwe Oelmueller, PreAnalytiX Management Co-Chair, will be a speaker at this valuable and insightful session amongst other experts in their fields.
Get more information here: